Predicting the intervention threshold for initiating osteoporosis treatment among postmenopausal women in China: A cost-effectiveness analysis based on real-world data
Osteoporosis International Nov 29, 2019
Cui L, He T, Jiang Y, et al. – Researchers developed a micro-simulation Markov model to determine FRAX-based fracture probabilities—specifically, osteoporosis states and relevant morbidities, including hip fracture, vertebral fracture, and wrist fracture—in Mainland China using real-world data, at which intervention could be cost-efficient. When the 10-year probability of major osteoporotic fracture on the basis of FRAX was >7%, treatment with zoledronate was cost-efficient. The FRAX threshold grew by age from 51 to 65 years old, and reduced in elder age groups, varying from 4% to 9%. In all, the extensive use of zoledronate was of both clinical and economic advantages among Chinese postmenopausal women. Moreover, using a FRAX-based intervention threshold of 7% with zoledronate should permit cost-efficient access to therapy to individuals, and contribute to decreasing the disease burden of osteoporosis in Mainland China.
Sign-up to continue reading. It is free & takes less than 2 mins
45 lakhs+ doctors trust M3 globally
Free & unlimited access to original articles and quizzes
Secure: we never sell your data
Sign up with M3 India to try daily quizzes and take part in competitionsTry M3 India / Log In
Why join our Market Research Panel?
- 10K+ Doctors participated in 40+ Indian and Global studies in 2018
- Average honorarium per study was Rs. 1,600 and total honoraria as high as Rs. 12,000 was earned by a Doctor